Hepatitis C patients may benefit from revaccination against hepatitis B after treatment

Recently published research from the University of Minnesota Medical School suggests individuals with hepatitis C should consider revaccination for hepatitis B. The study was published in the Journal of Infectious Diseases.

Licensing agreements for innovator GLP1R drugs weigh in with over $6.2bn in 2024 – Pharmaceutical Technology

Innovator drugs targeting glucagon-like peptide-1 receptor (GLP1R) witnessed a 595% increase in total licensing agreement deal value from 2019 to 2024 year-to-date (YTD), with more

August 21, 2024

Biocon slammed with OAI; Hong Kong looks to Wuxi for ADC abilities; Tanvex Pharma launches CDMO services

Welcome to Endpoints News’ manufacturing roundup, where we bring you essential updates on new builds, collaborations and more. This week we saw Biocon Biologics in

October 20, 2023

Pharmaceutical Compliance Software for the Pharma Industry

Pharmaceutical and biotechnology companies must maintain quality and meet stringent regulatory standards throughout their operations. Pharmaceutical compliance management software is designed to enhance patient safety

September 23, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.